Dicerna Pharmaceuticals Inc – Underwriting Agreements – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from SC 13G/A ~1 page Joint Filing Statement Pursuant to Rule 13d-1

from SC 13G/A 1 page Dated: February 14, 2020 Rtw Investments, LP By: /S/ Roderick Wong Roderick Wong, Managing Partner Rtw Master Fund, Ltd. By: /S/ Roderick Wong Roderick Wong, Director Roderick Wong By: /S/ Roderick Wong Roderick Wong, Individually

from SC 13G/A 1 page Joint Filing Statement Pursuant to Rule 13d-1

from 8-K 50 pages 7,680,492 Shares Dicerna Pharmaceuticals, Inc. Underwriting Agreement

from S-3 36 pages Dicerna Pharmaceuticals, Inc. $100,000,000 Common Stock Sales Agreement

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

from 8-K 50 pages 5,714,286 Shares Dicerna Pharmaceuticals, Inc. Underwriting Agreement

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

from 8-K 47 pages 2,750,000 Shares Dicerna Pharmaceuticals, Inc. Underwriting Agreement

from S-3 37 pages Dicerna Pharmaceuticals, Inc. 2,500,000 Shares Common Stock Sales Agreement

from S-1/A 42 pages [—] Shares of Common Stock Dicerna Pharmaceuticals, Inc. Underwriting Agreement